EPIX Pharmaceuticals
Studies conclude MS-325 (Vasovist) improves imaging in MRA
Published in Telemedicine Business Week, September 21st, 2005
Results from MS-325-12 and MS-325-13 were published in the July and September 2005 issues of the journal Radiology. The articles indicate that MS-325, a contrast agent designed specifically for vascular imaging with magnetic resonance angiography (MRA), provides higher quality images of the aortoiliac vessels resulting in better agreement with x-ray angiography, the standard of reference, than noncontrast MRA. MS-325 is being codeveloped by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
More Articles from Telemedicine Business Week
- Finance
CCA has entered into an agreement for a private placement of its common stock - Image Technology Laboratories
Medical imaging company improves cash position and liquidity - Oridion Systems
Medical device company revenues increased 24% in second quarter of 2005 - VisEn Medical
Molecular imaging products company raises $4 million venture capital financing - Xenogen Corp.
Biophotonic imaging company completes $15 million private equity financing - Apical Ballooning Syndrome
Clinical features elucidated via myocardial contrast echocardiography - More from this issue of Telemedicine Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
